arrow
M

Matthew D. Ringel

University System of Ohio
H指数:79
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer

2025年美国甲状腺协会成人分化型甲状腺癌管理指南

Thyroid
IF6.7
2025-08-200
PRE
CHEK2 Founder Variants and Thyroid Cancer Risk
THYROID
IF6.7
2024-02-273
PRE
Dabrafenib Versus Dabrafenib plus Trametinib in BRAF-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial

Dabrafenib与Dabrafenib联合曲美替尼治疗BRAF突变的放射性碘难治性分化型甲状腺癌的比较: 一项随机、2期、开放标签多中心试验的结果

THYROID
IF6.7
2022-07-0570
OA
GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer (vol 11, 3981, 2020)

促甲状腺激素的gis突出了多效性作用和与甲状腺癌的逆关联 (第11卷,3981,2020)

2021-12-161
OAAI